Major Pharmaceuticals Native Starch Market Trend 2025-2034: The Evolution Of Starch Solutions

June 19, 2025 09:39 AM BST | By EIN Presswire
 Major Pharmaceuticals Native Starch Market Trend 2025-2034: The Evolution Of Starch Solutions
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The pharmaceuticals native starch market has seen substantial growth recently, escalating from $5.65 billion in 2024 to a projection of $6.17 billion in 2025 with a Compound Annual Growth Rate CAGR of 9.1%. Factors contributing to this escalation include a rising demand for natural excipients, expanding pharmaceutical production, growing preference for biocompatible ingredients, increased manufacturing of generic drugs, and increasing regulatory support for natural ingredients.

What Is The Projected Future Growth Of The Pharmaceuticals Native Starch Market Size?
The pharmaceuticals native starch market is expected to maintain strong growth over the next few years, climbing to $8.69 billion in 2029 with a CAGR of 8.9%. This forecasted growth can be attributed primarily to rising investment in pharmaceutical innovation, heightened focus on sustainable sourcing, expanding applications in new drug formulations, increasing demand for clean-label pharmaceutical products, and escalating healthcare expenditure in emerging markets. Additionally, key trends that are likely to impact the market in the forecast period include technological advancements in starch processing, innovations in drug delivery systems, developments in bio-based pharmaceutical ingredients, significant research and development in plant-based excipients, and the development of both solubility and stability solutions.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

What Are The Key Drivers Propelling The Growth Of The Pharmaceuticals Native Starch Market?
The climbing prevalence of chronic diseases is likely to be a key growth driver for the pharmaceuticals native starch market. Chronic diseases are medical conditions that typically progress slowly and endure for more than a year. As the aging population continues to rise, so does the prevalence of these long-lasting conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more common with age. Pharmaceuticals native starch proves instrumental in managing these chronic diseases by enhancing drug formulation stability, increasing bioavailability, enabling controlled drug release, supporting patient compliance, and ultimately, improving effectiveness and long-term management of these medical conditions.

What Key Player Strategies Are Driving The Pharmaceuticals Native Starch Market?
Major companies operating in the pharmaceuticals native starch market include Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products India Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are The Emerging Trends In The Pharmaceuticals Native Starch Market?
Key players in the pharmaceuticals native starch market are pioneering innovative products such as plant-based textures to enhance drug formulations and improve patient compliance. These physical properties derived from plant ingredients enhance tablet binding, disintegration, and mouthfeel for improved natural drug formulations.

How Is The Pharmaceuticals Native Starch Market Segmented?
The pharmaceuticals native starch market is classified into five key segments:
1 By Type: Potato Starch, Corn Starch, Other Types
2 By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3 By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4 By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5 By End-User: Pharmaceutical Manufacturers, Contract Research Organizations CROs, Contract Manufacturing Organizations CMOs, Research And Development Labs, Academic Institutions, Other End-users
Additionally, subsegments include:
1 By Potato Starch: Modified Potato Starch, Native Potato Starch
2 By Corn Starch: Modified Corn Starch, Native Corn Starch
3 By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Are The Regional Insights In The Pharmaceuticals Native Starch Market?
North America led the pharmaceuticals native starch market in 2024. However, Asia-Pacific is expected to be the fastest-growing region in the forthcoming years. Regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Radiopharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report

Generic Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceuticals Market
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next